Efficacy of methotrexate in Cogan's syndrome.
L
L
Riente
E
E
Taglione
S
S
Berrettini
D000328:Adult; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D005938:Glucocorticoids / Q000627:therapeutic use; D006312:Hearing Loss, Bilateral / Q000188:drug therapy* / Q000276:immunology; D006319:Hearing Loss, Sensorineural / Q000188:drug therapy* / Q000276:immunology; D006320:Hearing Tests; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007634:Keratitis / Q000276:immunology; D008727:Methotrexate / Q000627:therapeutic use*; D008775:Methylprednisolone / Q000627:therapeutic use; D013577:Syndrome
D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D008775:Methylprednisolone; D008727:Methotrexate